A dual-targeting peptide-drug conjugate based on CXCR4 and FOLR1 inhibits triple-negative breast cancer.
基于 CXCR4 和 FOLR1 的双靶向肽-药物偶联物可抑制三阴性乳腺癌。
期刊:Acta Pharmaceutica Sinica B
影响因子:14.6
doi:10.1016/j.apsb.2025.06.012
Wang Kun, Wang Cong, Yang Hange, Chen Gong, Wang Ke, Ji Peihong, Sun Xudong, Fan Xuegong, Ma Jie, Cui Zhencun, Wang Xingkai, Tian Hao, Wu Dengfu, Wang Lu, Wang Zhimin, Liu Jiangyan, Yi Juan, Hu Kuan, Zhang Hailong, Wang Rui
